IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
33.85
-0.72 (-2.08%)
At close: Jan 2, 2026, 4:00 PM EST
33.66
-0.19 (-0.56%)
After-hours: Jan 2, 2026, 7:44 PM EST
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.97 billion as of January 2, 2026. Its market cap has increased by 36.30% in one year.
Market Cap
2.97B
Enterprise Value
1.86B
1-Year Change
36.30%
Ranking
Category
Stock Price
$33.85
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.97B, an increase of 1,276.61%. That is a compound annual growth rate of 48.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 498.15B |
| AbbVie | 405.67B |
| UnitedHealth Group | 300.29B |
| AstraZeneca | 288.12B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.85B |
| Novo Nordisk | 227.63B |